| The human acetylcholinesterase C-terminal T30 peptide activates neuronal growth through alpha 7 nicotinic acetylcholine receptors and the mTOR pathway A Graur, P Sinclair, AK Schneeweis, DT Pak, N Kabbani Scientific Reports 13 (1), 11434, 2023 | 14 | 2023 |
| A novel bioactive peptide, T14, selectively activates mTORC1 signalling: therapeutic implications for neurodegeneration and other Rapamycin-Sensitive Applications S Ranglani, A Ashton, K Mahfooz, J Komorowska, A Graur, N Kabbani, ... International Journal of Molecular Sciences 24 (12), 9961, 2023 | 7 | 2023 |
| Protein Painting Mass Spectrometry in the Discovery of Interaction Sites within the Acetylcholine Binding Protein A Graur, A Haymond, KH Lee, F Viscarra, P Russo, A Luchini, M Paige, ... ACS Chemical Neuroscience, 2024 | 2 | 2024 |
| The human acetylcholinesterase c-terminal T30 peptide activates neural growth through an alpha 7 nicotinic acetylcholine receptor mTOR pathway A Graur, N Kabbani bioRxiv, 2023.04. 07.536081, 2023 | 2 | 2023 |
| Using Protein Painting Mass Spectrometry to Define Ligand Receptor Interaction Sites for Acetylcholine Binding Protein A Graur, N Erickson, N Kabbani Bio-protocol 15 (2), e5163, 2025 | | 2025 |
| Proteomic analysis of dorsal root ganglia in a mouse model of paclitaxel-induced neuropathic pain R Hanna, A Graur, P Sinclair, BD Mckiver, PD Bos, MI Damaj, N Kabbani Plos one 19 (9), e0306498, 2024 | | 2024 |
| Targeting the Cholinergic Synapse in Development and Disease A Graur George Mason University, 2024 | | 2024 |
